Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b603ecd95b3b1497ae9f30752a676c0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ae0d4e4b5a64a9a532bffd8513ed029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f352cc5bd193c17ffff15bf60e16f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdbef338e2d6b9436699241e1042beb8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B50-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
filingDate |
2014-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df5f53262999523af25996750d74e386 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87d73674f4d6ed69a7cf665806941edc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95d3540b9c1752c2d0da979613c6a2f |
publicationDate |
2016-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016237142-A1 |
titleOfInvention |
Synthetic Single Domain Antibody |
abstract |
The invention relates to the identification of a highly stable single domain antibody scaffold (hs2d Ab) and its use in generating synthetic single domain antibody library (hs2d Ab-L1). The invention also relates to antigen-binding proteins comprising said stable single domain antibody scaffold and their uses, in particular as therapeutics. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10982210-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357865-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019166877-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023044272-A1 |
priorityDate |
2013-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |